Articoli
Recommendations for the management of Carbapenem-resistant Enterobacteriaceae (CRE) in acute and long-term acute care hospitals.
Minnesota Department of Health. Aprile 2011
Guidelines for the prevention and control of multi-drug resistant organisms (MDRO) excluding MRSA in the healthcare setting. 2012
Dublin: Royal College of Physicians (RCPI) Healthcare Associated Infections of Ireland in association with HSE Quality and Patient Safety
Acute trust toolkit for the early detection, management and control of Carbapenemase-producing Enterobacteriaceae.
Public Health England, 2013
Circolare ministeriale “Sorveglianza, e controllo delle infezioni da batteri produttori di Carbapenemasi (CPE)”
Circolare Ministeriale. Febbraio 2013
Acute trust toolkit for the early detection, management and control of Carbapenemase-producing Enterobacteriaceae. Relevant literature and resources.
Public Health England, 2014.
Updated guidelines on screening for carriage of resistant Enterobacteriaceae in Ireland.
Dublin: Royal College of Physicians (RCPI). 2014
Systematic review of the effectiveness of infection control measures to prevent the transmission of Carbapenemase-producing Enterobacteriaceae through cross-border transfer of patients.
ECDC Technical Report, 2014
AHRQ. Carbapenem-Resistant Enterobacteriaceae (CRE) control and prevention toolkit.
Agency for Healthcare Research and Quality U.S. Department of Health and Human Services, 2014
ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant gram-negative bacteria in hospitalized patients.
ESCMID Linee guida. 2014